
‘Dementia is just one part of who they are. My husband's underlying personality hasn't really changed'
Nuala and Gerry Paley first met when she was 21 and he was 23. Their relationship didn't take off properly in the beginning, but they met again eight years later and were married within six months.
The couple, now aged 69 and 71, are living with the difficulty of early-onset
Alzheimer's
as Gerry was diagnosed with it in 2017, when he was just 63.
'I first saw changes in Gerry about a year before his diagnosis,' says Nuala. 'I noticed a change in his mood, and in his outlook on things. He was repeating himself, and seemed less aware of what he was talking about and what he was saying. The changes were subtle, but they were there. At that stage I had lived with him for 30 years, and when you're with someone that long, you notice these things.
'He was diagnosed in 2017 and now, some days it can be difficult to get him out of bed. Although he washes and dresses himself, I have to remind him to change, and I leave everything out for him and remind him constantly to move on to the next thing – for example, if he puts something into the microwave, he will think that he has eaten, so I will have to remind him.
READ MORE
'Mornings are busy generally, as he has several activities which I drive him to, and he loves walking our dog, Teddy, in the afternoon. He has the same route every day, and always ends up in the local cafe for a coffee, but, after that, the days can be long. Dementia brings many challenges, as anyone dealing with the condition will know and it is getting more stressful as Gerry's memory problems become more persistent.
'I have had my own medical issues over the past while, so it's very hard to keep up at times. It can be like Groundhog Day, every day, and the stress can be intense. I have wonderful friends, but I am very aware they have their own lives too.'
But despite the issues the Wicklow couple face on a daily basis, they have a strong relationship. Nuala says the most important thing for carers to do is to take any support offered, as some days are very difficult.
'We love each other, so it's very important to see the person beyond the condition,' she says. 'Dementia is just one part of who they are and Gerry's underlying personality hasn't really changed. He is very sociable, and loves being with other people. He is a very caring and kind person and is always looking out for others – he still has these characteristics.
'Of course, he might not realise that he has spoken to you about the same thing multiple times – but that's just something I have to accept, especially as what he says can be very wise. My advice to other carers is to talk, talk, talk – to whoever can offer help, information and support. I would encourage them to enrol in a carer's course, join support groups and get in touch with the
Alzheimer Society of Ireland
(ASI) to learn more about their services and supports.
'Gerry and I avail of the ASI's Day Care at Home Service and, twice a week, Lorna from the ASI comes to spend time with Gerry. They have the chats, play board games, go for walks with Teddy or grab a coffee. This gives me a break and takes away some of my stress; it makes a huge difference to our lives.'
Women over the age of 60 are twice as likely to develop Alzheimer's disease as they are to develop breast cancer during their lifetime
—
Report by Alzheimer's Research UK
Gerry and Nuala became members of the
Irish Dementia Working Group
and the Dementia Carers Campaign Network, advocacy groups that help to raise awareness of issues affecting people and families coping with dementia in Ireland. 'Our advocacy work has been incredibly rewarding – knowing that we are helping to ensure that the voices of people with dementia and their carers and families are heard,' says Nuala. 'Connecting with others who are in similar situations – whether they are caring for a loved one with dementia or living with the condition themselves – it gives you a sense of comfort and strength. Dementia affects so many families across the country, and Gerry and I want people like us to know that they are not alone.
'We need to stand back and admit we are only human and can only take so much – and we need huge supports to keep going day to day.'
Gerry and Nuala Paley. Photograph: Karen Morgan
Although dementia affects people of varying ages, Dr Laura O'Philbin, research and policy manager at the Alzheimer Society of Ireland says that women are much more likely to be affected by the condition, as figures show that women account for almost two-thirds of people living with dementia.
'A report by Alzheimer's Research UK published in 2022 highlighted that women over the age of 60 were twice as likely to develop Alzheimer's disease as they are to develop breast cancer during their lifetime,' she says. 'Women also play a significant role in caregiving, with approximately two-thirds of primary caregivers for people with dementia being female – this is supported by Irish census data. And as well as more often providing care, women tend to provide more intense levels of care and, in some cases, experience greater stigma and reduced social support compared to male caregivers.'
[
The year of hope: 'Exciting' advances achieved in search to reverse Alzheimer's disease
Opens in new window
]
In addition to this, Dr O'Philbin says women living with dementia may encounter unique challenges, including the compounded effects of ageism, sexism and ableism. 'These intersecting stigmas can result in social isolation and barriers to care. Traditional gender roles further complicate matters, as women are often seen as caregivers rather than care recipients, which can heighten feelings of guilt or inadequacy following a dementia diagnosis.
'This is a double-edged sword because, at the same time, the societal expectation for women to take on caregiving responsibilities, combined with limited recognition of caregiving as a valued role, has contributed to challenges for male caregivers. Some men report stigma which can lead to a reluctance in asking for or accepting help.'
About Dementia
According to the Alzheimer Society of Ireland, there are an estimated 64,000 people with dementia in Ireland.
The number of people with the condition is expected to reach 150,000 by 2045.
Globally, women account for about two-thirds of people living with dementia. This disparity is likely due to a combination of biological, genetic and social factors.
Ongoing research suggests that hormonal changes post-menopause and genetic risk factors, such as the APOE4 gene, contribute to the higher prevalence of dementia among women.
Although men and women are equally likely to carry the APOE4 gene, its association with dementia risk appears stronger in women, though the underlying reasons for this difference are not fully understood. Women's longer life expectancy also increases their likelihood of developing age-related conditions such as dementia.
Often, the early signs of dementia may be difficult to detect. Some people experience changes in their short-term memory early on, for others changes to mood or to language may be the early signs. Each person's experience with dementia is unique.
In general, early signs and symptoms can include:
Memory loss, particularly for recent events
Problems with language; difficulty finding the right word
Changes in mood and behaviour
Becoming confused in familiar surroundings or situations
Difficulty in following conversations, TV programmes or reading
Difficulty managing money and everyday tasks
Difficulty solving problems or doing puzzles
Loss of interest in hobbies and pastimes, lack of initiative to start something or go somewhere.
Repeating a question or story several times without realising
If you are experiencing any of these symptoms, it is advisable to make an appointment with your GP to discuss or contact the ASI's National and Free Confidential Helpline at 1800-341341 or
alzheimer.ie

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Irish Daily Mirror
2 days ago
- Irish Daily Mirror
Top doc recommends getting rid of everyday tool to reduce risk of Alzheimer's
There is "such positivity" in Alzheimer's research at the moment, says top immunologist Luke O'Neill. A drug that slows down the disease was recently approved by the European Medicines Agency (EMA), and it is hoped that it will be available in Ireland soon. However, the expert stresses that lifestyle changes can help lower a person's chance of developing the disease. Alzheimer's is the most common form of dementia, which is the umbrella term for memory loss and other cognitive abilities that are serious enough to interfere with daily life. It is primarily caused by the build-up of protein deposits in the brain that eventually kills brain cells. While the exact cause of Alzheimer's is unknown, scientists believe that for most people it is caused by a combination of genetic, lifestyle and environmental factors. In July 2024, the Lancet Commission reported that 45 per cent of dementia cases could be prevented by fully addressing 14 lifestyle factors. Here are Luke O'Neill's and the Lancet's lifestyle recommendations on reducing the risk of Alzheimer's- and it includes ditching a tool most of us use daily. Google Maps is a tool that many of us use daily, however, studies suggest that keeping our brains as active as we can can reduces the risk of Alzheimer's. This can be done by learning a new language, doing puzzles, taking part in quizzes and also by navigating new areas and figuring out directions ourselves. A study published in The BMJ in December 2024 found that taxi drivers and ambulance drivers have the lowest rates of death due to Alzheimer's. Other drivers such as airline pilots or bus drivers - those that have predefined routes - did not have a lower risk of developing the disease. This suggests that occupations requiring frequent navigational and spatial processing could offer some protection against Alzheimer's. Social interaction is a great way to keep the mind active, and scientists have identified social isolation as a risk factor for not only Alzheimer's but hypertension and coronary heart disease. Loneliness can be associated with decreased cognitive activity, which can accelerate cognitive decline and poor mood. Professor O'Neill told the Irish Mirror: "A big one is loneliness, that is a risk factor for developing Alzheimer's and Dementia. We have to mind older people, many older people get isolated and with some encouragement we can hopefully diminish the loneliness epidemic that's there." Studies strongly suggest a link between hearing loss and a higher risk of developing dementia. One found that with every 10-dB decrease in hearing ability, there is a 4 per cent to 24 per cent higher risk of developing dementia. Professor O'Neill encourages everyone to be conscious of their hearing and get it checked if they believe it might be declining. He added: "With a hearing aid you can stave that off, so the big message that's been given in the last while is if you are having trouble hearing go and get a hearing aid because it's a risk of getting Alzheimer's. "These are things we can all do at decreasing our own risk of getting it, and they are very optimistic on that front." The newest Lancet Commission study on dementia reported that high LDL cholesterol is associated with a higher risk of dementia. LDL is commonly known as "bad cholesterol", it's a condition where there's excessive amount of LDL cholesterol in the bloodstream. This is usually checked during a routine bloods appointment, often in a GP office. Luckily, much can be done to reduce LDL cholesterol including a balanced diet low in saturated and trans fats. This is usually found in foods like red meat, full-fat dairy, fried foods and processed snacks. Lifelong learning is associated with improved brain health, with higher levels of cognitive activity. This doesn't mean you have to enroll in a degree programme, but learning a new language or taking up a new skill, even casually, can improve brain health. The Lancet Commission found that those who did not complete secondary school education were more at-risk of developing Alzheimer's. Being active is important for a healthier life, and it has been cited as one of the 14 factors that could reduce the risk of dementia. Physical activity can benefit brain health by reducing chronic inflammation, improving blood flow and increasing the release of protein that is good for brain cells. The World Health Organisation recommends that adults get between 150 and 300 minutes of moderate-intensity aerobic physical activity a week. This would include walking briskly, biking, swimming or dancing. It also recommends that on top of this adults should partake in muscle strengthening activities two times a week. Obesity is also a risk factor for developing Alzheimer's disease. However, it's important to note that BMI is not definitive in diagnosing obesity- as some people can have a high percentage of muscle mass. Calculating body fat percentage, or measuring waist-to-hip ratio can be used to determine a healthy body. An analysis published in the National Library of Medicine with over five million people found that those with higher central obesity - measured by waist-to-hip ratio- was associated with a greater risk of cognitive impairment and dementia.


RTÉ News
4 days ago
- RTÉ News
'Hope on horizon' as new drugs tested for Alzheimer's treatment
Dementia experts have said that "hope is on the horizon" after a new review shows a rise in the number of potential drugs that could treat or prevent Alzheimer's disease. Some 138 new treatments are being assessed for the treatment and prevention of Alzheimer's. A third of drugs currently being trialled are "repurposed" medications that are already being used to tackle other diseases, including diabetes, multiple sclerosis and cholesterol, according to the new review. One such trial is assessing whether semaglutide, the main ingredient for the weight loss and diabetes drug Ozempic and weight loss drug Wegovy, can slow the progression of dementia. And four late-stage trials are looking at preventing disease. Experts said that drugs targeting amyloid protein build up in the brain, such as lecanemab and donanemab, are "only one part of the overall strategy" as they expressed excitement over the variety of new drugs, which are being tested among patients. The new review of Alzheimer's disease in clinical trials in 2025 found 182 clinical trials assessing the impact of 138 drugs. The number of trials represents an 11% increase on the previous year, according to the review, which was led by an expert from the University of Nevada in the US and has been published in the journal Alzheimer's and Dementia: Translational Research and Clinical Interventions. Commenting on the paper, Dr Sheona Scales, director of research at Alzheimer's Research UK, said: "This year has really given us real cause for optimism." She said that as well as more drugs coming through the pipeline, the treatment targets are "more diverse" and "looking at all stages of the disease". She added: "What this paper is showing us is that the pipeline of drug development is growing, it's diversifying and accelerating." "This latest report shows us that there is hope on the horizon for people with Alzheimer's, building on lecanemab and donanemab." Dr Emma Mead, chief scientific officer of the Oxford Drug Discovery Institute, added: "Today we are at a tipping point in dementia research as we understand more and more about the diseases that drive dementia. "This gives us opportunities to slow and ultimately stop this devastating condition and today's announcement demonstrates that researchers are able to translate these understandings towards potential new treatments." James Rowe, professor of cognitive neurology at the University of Cambridge and consultant neurologist, said: "What strikes me is not just the number of new drugs, which is increasing year on year, but their range of targets (and) the range in which they work, giving us multiple shots on goal." On the drugs which are being investigated for the prevention of disease, Prof Rowe said: "One of the most exciting things of this report is the number of large-scale late-stage trials on prevention. "And the aspiration to prevent, not just treat, is starting to be seen in the figures we see in these charts today." He added: "One way this can work is you take a treatment that you show to be working in people with symptoms with the illness, and then you simply bring it forward by some years. "The ones that are in trial at the moment are really... bringing forward an effective treatment to earlier stage." For instance, people with a genetic risk of Alzheimer's could receive some drugs earlier to see if they protect against the disease. On the repurposing of current drugs, Dr Mead said that it can usually take ten to 15 years for new drugs to be tested and approved for use. "Being able to repurpose drugs licensed for other health conditions could help to accelerate progress and help to open up other avenues to prevent or treat dementia causing diseases," she said. "A really promising example of this is the drug semaglutide, which is currently being trialled in people with mild cognitive impairment." Meanwhile, academics said lecanemab and donanemab, which can be used for treating mild cognitive impairment in Alzheimer's patients, are an "important first step" in the battle against the disease. The treatments were initially approved for UK use by regulators but then deemed not cost-effective for NHS use. The National Institute for Health and Care Excellence (NICE) is taking more evidence on donanemab and lecanemab and is expected to announce its decision in the summer. Dr Scales added: "Lecanemab and donanemab have represented a huge leap forward in our understanding and ability to be able to treat Alzheimer's disease. "What they've done is they've proved that we're able to modify the course of Alzheimer's disease, and what that has done is opened up the door to future treatments that we hope are more effective, easier to deliver and able to deliver for our patients." She said studies are showing "even more complexities" around Alzheimer's and that in the future, people may be treated with a combination of drugs, depending on when they are diagnosed and the type of dementia they have.


Irish Independent
30-05-2025
- Irish Independent
Drogheda Alzheimer's takes another step toward creating a dementia-inclusive community
Drogheda's Alzheimer's at Tredagh Lodge is focused on providing vital care for people living with Alzheimer's and dementia, working with each person to ensure they feel comfortable and supported and their individual needs are met. Certificates were recently presented to local businesses and organisations, bringing the total number of individuals who have participated to over 30, representing 25 businesses and groups in Drogheda. Chair of Drogheda Alzheimer's (Tredagh Lodge Day Care Centre), Gerry Leydon, together with committee members Aileen Murphy, Ann Shortt, and Noel Heeney, presented certificates to those who took part. The nine businesses represented included: Paddy Dwyer's and Owen Fox's on Shop Street; John Hurley Bros; Wool Works and Superpharm on West Street; Peter Street Pharmacy; Abacas School; and Tanya Adair and Siobhan from Louth Local Development. The latest workshop follows the launch of the initiative last summer and the first training workshop held in September 2024. The initiative remains focused on increasing dementia awareness through ongoing training and education. It continues to make strides in Drogheda toward becoming a community where individuals with dementia are understood, respected, and supported. Another event will be planned for September, and Drogheda's Tredagh Lodge has encouraged new businesses and organisations to take part. The charity has also asked other existing participants to expand their involvement. The group is also actively working on plans to hold its first Sporting Memories event on July, 5 working with Drogheda United. The Sporting Memories initiative is a community-based program designed to support individuals living with dementia through the shared joy of reminiscing about sports. By recalling memorable sporting events, participants can reconnect with their past, fostering a sense of identity and community engagement. Details on this event will be made available soon.